| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.16 | 2e-06 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.12 | 7e-05 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0001 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.17 | 0.0003 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0004 |